Trial Profile
A phase I study of liposomal annamycin in adult patients with relapsed or refractory acute myeloid leukemia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Jun 2017
Price :
$35
*
At a glance
- Drugs Annamycin (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 01 Jun 2017 New trial record
- 23 May 2017 Results (n=16) published in a Moleculin Biotech media release.